ARTICLE | Finance
HyperAcute IPO
Cancer vaccine play NewLink hopes IPO will raise $60M
November 7, 2011 8:00 AM UTC
Cancer vaccine company NewLink Genetics Corp. is hoping to get its IPO out the door this week.
The Iowa biotech hopes to sell 5.5 million shares at $10-$12. An $11 price would raise $60.5 million and value NewLink at $198.2 million...